APA (7th ed.) Citation

Oda, N., Mitani, R., Takata, I., & Kataoka, M. (2022). Interstitial lung disease after receiving the mRNA-based COVID-19 vaccine tozinameran. Elsevier.

Chicago Style (17th ed.) Citation

Oda, Naohiro, Reo Mitani, Ichiro Takata, and Mikio Kataoka. Interstitial Lung Disease After Receiving the MRNA-based COVID-19 Vaccine Tozinameran. Elsevier, 2022.

MLA (9th ed.) Citation

Oda, Naohiro, et al. Interstitial Lung Disease After Receiving the MRNA-based COVID-19 Vaccine Tozinameran. Elsevier, 2022.